Literature DB >> 18579612

Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.

Rebekah Stackpole Zimmerman1, Naomi Rosenberg.   

Abstract

Transformation by Abelson murine leukemia virus (Ab-MLV) is a multistep process in which growth-stimulatory signals from the v-Abl oncoprotein and growth-suppressive signals from the p19(Arf)-p53 tumor suppressor pathway oppose each other and influence the outcome of infection. The process involves a proliferative phase during which highly viable primary transformants expand, followed by a period of marked apoptosis (called "crisis") that is dependent on the presence of p19(Arf) and p53; rare cells that survive this phase emerge as fully transformed and malignant. To understand the way in which v-Abl expression affects p19(Arf) expression, we examined changes in expression of Arf during all stages of Ab-MLV transformation process. As is consistent with the ability of v-Abl to stimulate Myc, a transcription factor known to induce p19(Arf), Myc and Arf are induced soon after infection and p19(Arf) is expressed. At these early time points, the infected cells remain highly viable. The onset of crisis is marked by an increase in p19(Arf) expression and a change in localization of the protein from the nucleoplasm to the nucleolus. These data together suggest that the localization and expression levels of p19(Arf) modulate the effects of the protein during oncogenesis and reveal that the p19(Arf)-mediated response is subject to multiple layers of regulation that influence its function during Ab-MLV-mediated transformation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579612      PMCID: PMC2519686          DOI: 10.1128/JVI.00348-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Transforming pathways activated by the v-Abl tyrosine kinase.

Authors:  Scott K Shore; Ramana V Tantravahi; E Premkumar Reddy
Journal:  Oncogene       Date:  2002-12-09       Impact factor: 9.867

2.  ARF function does not require p53 stabilization or Mdm2 relocalization.

Authors:  Chandrashekhar Korgaonkar; Lili Zhao; Modestos Modestou; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

4.  Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.

Authors:  J D Weber; M L Kuo; B Bothner; E L DiGiammarino; R W Kriwacki; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

5.  The absence of Msh2 alters abelson virus pre-B-cell transformation by influencing p53 mutation.

Authors:  J Jenab-Wolcott; D Rodriguez-Correa; A H Reitmair; T Mak; N Rosenberg
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.

Authors:  Masaaki Matsuoka; Megumi Kurita; Haruka Sudo; Kiyohisa Mizumoto; Ikuo Nishimoto; Etsuro Ogata
Journal:  Biochem Biophys Res Commun       Date:  2003-02-21       Impact factor: 3.575

7.  Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.

Authors:  S Llanos; P A Clark; J Rowe; G Peters
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

8.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 9.  Tumor suppression by Ink4a-Arf: progress and puzzles.

Authors:  Scott W Lowe; Charles J Sherr
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

10.  Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.

Authors:  C A Mainville; K Parmar; I Unnikrishnan; L Gong; G D Raffel; N Rosenberg
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more
  1 in total

1.  Heterokaryon technique for analysis of cell type-specific localization.

Authors:  Roseann Gammal; Krista Baker; Destin Heilman
Journal:  J Vis Exp       Date:  2011-03-11       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.